Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients

Vincent Lo Re,Craig Newcomb,Dena M. Carbonari,Jason Roy,Keri N. Althoff,Mari M. Kitahata,Krishna P. Reddy,Joseph K. Lim,Michael J. Silverberg,Angel M. Mayor,Michael A. Horberg,Edward R. Cachay,Gregory D. Kirk,Mark W. Hull,John Gill,Timothy R. Sterling,Jay R. Kostman,Marion G. Peters,Richard D. Moore,Marina B. Klein,H. Kim

Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients

2019

Background:Hepatitis B virus (HBV) infection is a leading cause of end-stage liver disease (ESLD) and hepatocellular carcinoma (HCC) in HIV. Factors contributing to the high rates of liver complications among HIV/HBV-coinfected individuals remain unknown.Setting:North American AIDS Cohort Collaborat

Keywords:

Immunology
Virology
Hepatitis B virus
Medicine
Cohort
high rate
HIV/AIDS
Liver disease
Hepatocellular carcinoma
human immunodeficiency virus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations